So should Cullinan Therapeutics ( NASDAQ:CGEM) shareholders be worried about its cash burn? For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback